Ethical and regulatory challenges associated with the exception from informed consent requirements for emergency research: From experimental design to institutional review board approval

Archives of Surgery

Volumn 141, Issue 10, 2006, Pages 1019-1023

  Vaslef, Steven N ^a   Cairns, Charles B ^a   Falletta, John M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMMUNITY CARE; EMERGENCY CARE; EXPERIMENTAL DESIGN; HEALTH CARE PERSONNEL; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; MEDICAL RESEARCH; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

CRITICAL ILLNESS; EMERGENCY TREATMENT; ETHICS COMMITTEES, RESEARCH; ETHICS, CLINICAL; FEDERAL GOVERNMENT; GOVERNMENT REGULATION; HUMANS; INFORMED CONSENT; RISK ASSESSMENT; STATE GOVERNMENT; THERAPEUTIC HUMAN EXPERIMENTATION; UNITED STATES;

EID: 33750058249     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.141.10.1019     Document Type: Review

References (17)

1. Trials of War Criminals Before the Nuremberg Military Tribunals Under Control Council Law No. 10. Washington, DC: US Government Printing Office; 1949: 181-182.
2. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. 2004. http://www.wma.net/e/ policy. Accessed February 8, 2005.
3. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: US Government Printing Office; 1978. DHEW Publ (OS) 78-0012.
4. Food and Drug Administration. Protection of human subjects; informed consent; final rule. Fed Regist. 1996;61:51498-51531.
5. National Institutes of Health; Department of Health and Human Services. Waiver of informed consent requirements in certain emergency research. Fed Regist. 1996;61:51531-51533.
6. Exception from informed consent for studies conducted in emergency settings: regulatory language and excerpts from preamble. US FDA Information Sheets: Guidance for Institutional Review Boards and Clinical Investigators 1998 Update. http://www.fda.gov/oc/ohrt/irbs/except.html. Accessed February 11, 2005.
7. Biros MH. Research without consent: current status, 2003. Ann Emerg Med. 2003;42:550-564.
8. Bircher NG. Resuscitation research and consent: ethical and practical issues. Crit Care Med. 2003;31(5)(suppl):S379-S384.
9. Cone DC, O'Connor RE. Are US informed consent requirements driving resuscitation research overseas? Resuscitation. 2005;66:141-148.
10. Food and Drug Administration. Protection of human subjects; informed consent; proposed rule. Fed Regist. 1995;60:49086-49103.
11. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317:141-145.
12. King NMP. Defining and describing benefit appropriately in clinical trials. J Law Med Ethics. 2000;28:332-343.
13. Kremers MS, Whisnant DR, Lowder LS, Gregg L. Initial experience using the Food and Drug administration guidelines for emergency research without consent. Ann Emerg Med. 1999;33:224-229.
14. Mosesso VN Jr, Brown LH, Greene HL, et al. Conducting research using the emergency exception from informed consent: the Public Access Defibrillation (PAD) Trial experience. Resuscitation. 2004;61:29-36.
15. Quinn SC. Ethics in public health research: protecting human subjects: the role of community advisory boards. Am J Public Health. 2004;94:918-922.
16. Biros MH, Fish SS, Lewis RJ. Implementing the Food and Drug Administration's Final Rule for waiver of informed consent in certain emergency research circumstances. Acad Emerg Med. 1999;6:1272-1282.
17. Resuscitation Outcomes Consortium. https://roc.uwctc.org. Accessed July 21, 2005.